相关实验视频
Updated: May 14, 2025

07:47
Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
15.4K
记录了肺炎球菌结合疫苗在印度引入的旅程
Pawan Kumar1, Arindam Ray2, Amrita Kumari2
1Immunization Division, Ministry of Health & Family Welfare, Government of India, New Delhi 110011, India.
Vaccines
|May 7, 2025
概括
印度 印度 印度
科学领域:
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
- 儿童传染病 儿童传染病
背景情况:
- 肺炎是全球五岁以下儿童死亡的主要原因,每年约有70万例死亡.
- 印度卫生和家庭福利部 (MoHFW) 实施了到2021年在全国范围内逐步推出肺炎球菌结合疫苗 (PCV).
- 尽管面临重大挑战,包括COVID-19大流行,但PCV运动取得了全国范围的覆盖.
研究的目的:
- 审查关键的决策,流程和利益相关者合作,这对印度PCV在全国范围内成功推广起到了重要作用.
- 突出用于克服实施障碍的战略,特别是在COVID-19大流行期间.
主要方法:
- 进行了全面的书桌审查,分析了已出版和未出版的文献.
- 审查的重点是肺炎负担,PCV有效性和有效性,以及印度PCV引入和扩大规模的文件.
主要成果:
- 自2021年全国推出以来,印度的PCV覆盖率一直在稳步增加.
- 世界卫生组织 (WHO) 和联合国儿童基金会的估计表明,PCV助推剂覆盖率从2021年的25%大幅上升到2023年的83%.
- 这些覆盖率与世卫组织和联合国儿童基金会"预防和控制肺炎和腹全球行动计划" (GAPPD) 的目标一致.
结论:
- 由卫生健康部领导的全国PCV分阶段推广是一项雄心勃勃的倡议,尽管COVID-19大流行,但成功执行了.
- 卫生与妇女事务部,发展伙伴和利益相关方之间的密切合作对于应对推广的复杂性至关重要.
- 建议进一步研究PCV对抗生素耐药性的影响及其经济益处,以支持持续的融资和采购决策.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.0K
16:56Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
16.8K
相关概念视频
Pneumonia I: Introduction
191
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
191
Pulmonary Tuberculosis IV
123
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
123
Pulmonary Tuberculosis V
157
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
157
Pulmonary Tuberculosis I
210
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
210
Vaccinations
43.0K
Overview
43.0K
Acute Pharyngitis
278
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
278